These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 26423545)

  • 1. Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk.
    Seidman D; Averbach S; Smith-McCune K; Darney P
    Lancet HIV; 2015 Sep; 2(9):e365-6. PubMed ID: 26423545
    [No Abstract]   [Full Text] [Related]  

  • 2. Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk.
    Schooling CM
    Lancet HIV; 2015 Sep; 2(9):e366. PubMed ID: 26423548
    [No Abstract]   [Full Text] [Related]  

  • 3. Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk - Authors' reply.
    Noguchi LM; Richardson BA; Balkus JE; Marrazzo JM
    Lancet HIV; 2015 Sep; 2(9):e366-7. PubMed ID: 26423547
    [No Abstract]   [Full Text] [Related]  

  • 4. Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk - Authors' reply.
    Jones HE; van de Wijgert JH
    Lancet HIV; 2015 Sep; 2(9):e367. PubMed ID: 26423549
    [No Abstract]   [Full Text] [Related]  

  • 5. Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk.
    Hofmeyr GJ; Singata M; Lawrie TA; Temmerman M
    Lancet HIV; 2015 Sep; 2(9):e365. PubMed ID: 26423546
    [No Abstract]   [Full Text] [Related]  

  • 6. DMPA use and HIV acquisition: time to switch to NET-EN?
    Jones HE; van de Wijgert JH
    Lancet HIV; 2015 Jul; 2(7):e263-4. PubMed ID: 26423248
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.
    Noguchi LM; Richardson BA; Baeten JM; Hillier SL; Balkus JE; Chirenje ZM; Bunge K; Ramjee G; Nair G; Palanee-Phillips T; Selepe P; van der Straten A; Parikh UM; Gomez K; Piper JM; Watts DH; Marrazzo JM;
    Lancet HIV; 2015 Jul; 2(7):e279-87. PubMed ID: 26155597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research on hormonal contraception and HIV.
    Cates W;
    Lancet; 2014 Jan; 383(9914):303-4. PubMed ID: 24461116
    [No Abstract]   [Full Text] [Related]  

  • 9. Research on hormonal contraception and HIV.
    Gollub EL; Stein Z
    Lancet; 2014 Jan; 383(9914):304-5. PubMed ID: 24461117
    [No Abstract]   [Full Text] [Related]  

  • 10. Research on hormonal contraception and HIV.
    Redd AD
    Lancet; 2014 Jan; 383(9914):305. PubMed ID: 24461118
    [No Abstract]   [Full Text] [Related]  

  • 11. Research on hormonal contraception and HIV - Authors' reply.
    Ralph L; McCoy S; Hallett T; Padian N
    Lancet; 2014 Jan; 383(9914):305-6. PubMed ID: 24461119
    [No Abstract]   [Full Text] [Related]  

  • 12. Next steps for research on hormonal contraception and HIV.
    Ralph LJ; McCoy SI; Hallett T; Padian N
    Lancet; 2013 Nov; 382(9903):1467-9. PubMed ID: 23810224
    [No Abstract]   [Full Text] [Related]  

  • 13. The injectable contraceptive: present and future trends.
    Koetsawang S
    Ann N Y Acad Sci; 1991; 626():30-42. PubMed ID: 1829341
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential glucocorticoid receptor-mediated effects on immunomodulatory gene expression by progestin contraceptives: implications for HIV-1 pathogenesis.
    Hapgood JP; Ray RM; Govender Y; Avenant C; Tomasicchio M
    Am J Reprod Immunol; 2014 Jun; 71(6):505-12. PubMed ID: 24547700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between injectable progestin-only contraceptives and HIV acquisition and HIV target cell frequency in the female genital tract in South African women: a prospective cohort study.
    Byrne EH; Anahtar MN; Cohen KE; Moodley A; Padavattan N; Ismail N; Bowman BA; Olson GS; Mabhula A; Leslie A; Ndung'u T; Walker BD; Ghebremichael MS; Dong KL; Kwon DS
    Lancet Infect Dis; 2016 Apr; 16(4):441-8. PubMed ID: 26723758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive biological mechanisms support reassessment of use of the injectable contraceptive medroxyprogesterone acetate.
    Hapgood JP
    Endocrinology; 2013 Mar; 154(3):985-8. PubMed ID: 23429710
    [No Abstract]   [Full Text] [Related]  

  • 17. Depot medroxyprogesterone injectable contraception at the University of Uyo Teaching Hospital, Uyo.
    Abasiattai AM; Udoma EJ; Ukeme E
    Ann Afr Med; 2010; 9(2):81-5. PubMed ID: 20587929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal contraception and HIV risk: evaluating marginal-structural-model assumptions.
    Chen PL; Cole SR; Morrison CS
    Epidemiology; 2011 Nov; 22(6):877-8. PubMed ID: 21968782
    [No Abstract]   [Full Text] [Related]  

  • 19. Hormonal contraceptive use and women's risk of HIV acquisition: priorities emerging from recent data.
    Ralph LJ; Gollub EL; Jones HE
    Curr Opin Obstet Gynecol; 2015 Dec; 27(6):487-95. PubMed ID: 26536211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facts about once-a-month injectable contraceptives: memorandum from a WHO meeting.
    Bull World Health Organ; 1993; 71(6):677-89. PubMed ID: 8313486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.